Quest Diagnostics Dirección
Dirección controles de criterios 4/4
El CEO de Quest Diagnostics' es Jim Davis , nombrado en Nov 2022, tiene una permanencia de 1.42 años. compensación anual total es $12.67M, compuesta por 9.3% salario y 90.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.067% de las acciones de la empresa, por valor de $10.14M. La antigüedad media del equipo directivo y de la junta directiva es de 5.1 años y 7.5 años, respectivamente.
Información clave
Jim Davis
Chief Executive Officer (CEO)
US$12.7m
Compensación total
| Porcentaje del salario del CEO | 9.3% |
| Permanencia del CEO | 1.5yrs |
| Participación del CEO | 0.07% |
| Permanencia media de la dirección | 3.5yrs |
| Promedio de permanencia en la Junta Directiva | 7.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14
Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Quest Diagnostics declares $0.66 dividend
Nov 14Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 06Decode Health, Quest to collaborate to improve biomarker discovery for drug discovery
Oct 18Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Oct 06Quest Diagnostics to acquire select assets of Summa Health
Oct 05Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$842m |
| Dec 31 2023 | US$13m | US$1m | US$850m |
| Sep 30 2023 | n/a | n/a | US$759m |
| Jun 30 2023 | n/a | n/a | US$790m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$12m | US$806k | US$942m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$4m | US$625k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$4m | US$577k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$749m |
| Mar 31 2020 | n/a | n/a | US$771m |
| Dec 31 2019 | US$3m | US$590k | US$835m |
| Sep 30 2019 | n/a | n/a | US$709m |
| Jun 30 2019 | n/a | n/a | US$707m |
| Mar 31 2019 | n/a | n/a | US$720m |
| Dec 31 2018 | US$3m | US$590k | US$733m |
| Sep 30 2018 | n/a | n/a | US$860m |
| Jun 30 2018 | n/a | n/a | US$808m |
| Mar 31 2018 | n/a | n/a | US$782m |
| Dec 31 2017 | US$3m | US$590k | US$769m |
Compensación vs. Mercado: La compensación total ($USD12.67M) de Jim está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD13.51M).
Compensación vs. Ingresos: La compensación de Jim ha sido consistente con los resultados de la empresa en el último año.
CEO
Jim Davis (60 yo)
1.5yrs
Permanencia
US$12,673,834
Compensación
Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 1.5yrs | US$12.67m | 0.067% $ 10.8m | |
| Executive VP & CFO | 1.8yrs | US$3.98m | 0.019% $ 3.1m | |
| Senior VP & General Counsel | 24.8yrs | US$2.25m | 0.035% $ 5.6m | |
| Executive Vice President of Regional Businesses | no data | US$3.16m | 0.058% $ 9.4m | |
| Senior Vice President of Clinical Solutions | 1.8yrs | US$2.02m | 0.014% $ 2.2m | |
| Senior VP | 5.1yrs | sin datos | 0.032% $ 5.1m | |
| Senior VP | no data | sin datos | sin datos | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Senior VP & Chief Compliance Officer | 1.6yrs | sin datos | sin datos | |
| Senior VP & Chief Communications Officer | 27.5yrs | sin datos | sin datos | |
| Senior VP & Chief Human Resources Officer | 6.3yrs | sin datos | sin datos | |
| Senior Vice President of Strategy | 8.3yrs | sin datos | sin datos |
3.5yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de DGX se considera experimentado (3.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 1.5yrs | US$12.67m | 0.067% $ 10.8m | |
| Independent Director | 10.3yrs | US$315.44k | 0.019% $ 3.0m | |
| Lead Independent Director | 12.4yrs | US$345.94k | sin datos | |
| Independent Director | 19.4yrs | US$342.12k | sin datos | |
| Independent Director | 27.3yrs | US$304.82k | 0.028% $ 4.5m | |
| Independent Director | 5.3yrs | US$312.33k | 0.0026% $ 413.7k | |
| Independent Director | 9.8yrs | US$315.73k | 0.015% $ 2.4m | |
| Independent Director | 4.2yrs | US$300.44k | sin datos | |
| Independent Director | 2.8yrs | US$300.44k | sin datos | |
| Independent Director | less than a year | US$280.41k | sin datos |
7.5yrs
Permanencia media
65.5yo
Promedio de edad
Junta con experiencia: La junta directiva de DGX se considera experimentada (7.5 años de antigüedad promedio).